In this study we 
INTRODUCTION
Calcitonin (CT), a 32-amino-acid peptide hormone, is an important calciotropic hormone . Accordingly, high densities of CT receptors are present in bone cells (Nicholson et al., 1986) but are also present in kidney (Sexton et al., 1987 ) and brain (Fischer et al., 198 1a,b; Henke et al., 1983; Guidobono et al., 1987) . Although the physiological role of CT in the brain is unknown, central injection of salmon CT (sCT) induces potent effects, including analgesia (Pecile et al., 1975; Fabbri et al., 1985; Morton et al., 1986) , decreased appetite (Twery et al., 1982; Freed & de Beaurepaire, 1984; Tannenbaum & Goltzman, 1985) and gastric acid secretion (Morley et al., 1981; Maeda-Hagiwara & Watanabe, 1985; Lenz et al., 1986) , as well as modulation of secretion of prolactin (Chihara et al., 1982; Clementi et al., 1983) , growth hormone (Tannenbaum & Goltzman, 1985) and adrenocorticotropin (Rapisarda et al., 1984) .
In addition, central administration of CT may also affect the extrapyramidal motor system (Nicolletti et al., 1982; Twery et al., 1986) as well as directly altering membrane excitability of individual neurons (Gerber et al., 1985; Twery & Moss, 1985; Shimizu & Oomura, 1986) . These actions correlate well with the anatomical location of CT receptors in the central nervous system (Olgiati et al., 1983; Henke et al., 1983; Fabbri et al., 1985; Guidobono et al., 1986 Guidobono et al., , 1987 .
CT-receptor interactions have been studied in a number of tissues and cancer cell model systems. In most systems studied to date, the interaction of CT with its receptor results in virtually irreversible binding (Findlay et al., 1980; Lamp et al., 1981; Fischer et al., 198 lb; Chao & Forte, 1983; Nicholson et al., 1986 Nicholson et al., , 1988 . This kinetic behaviour is believed to be related to the persistent activation of adenylate cyclase in the CT-responsive cell line T47D (Lamp et al., 1981) and the prolonged action of CT in its major physiological target, the osteoclast (Nicholson et al., 1987) .
More recently, functional CT receptors have been solubilized from human placental membranes using the zwitterionic detergent CHAPS . The present paper describes the identification and solubilization of a CT binding site from sheep brain which displays reversible CT binding kinetics while retaining the ability to discriminate among CT analogues which would be expected for a CT receptor.
A preliminary report of this work was presented at the 10th International Conference on Calcium Regulating Hormones.
MATERIALS AND METHODS

Materials
Synthetic human CT (hCT) was provided by Dr. W. Rittel, Ciba-Geigy, Basel, Switzerland. Synthetic sCT, pig CT (pCT), des-Leu16-sCT and [Gly8]hCT and bovine parathyroid hormone-(1-34) were provided by Dr. R. C. Orlowski, Armour Pharmaceutical Co., Kanakee, IL, U.S.A. Epidermal growth factor was a gift from Dr [Arg""18, sCT were synthesized and purified as described previously and both peptides were equipotent with native sCT in biological assay . 125I-labelled sCT was prepared as described (Findlay et al., 1980) . Specific radioactivities ranged from 150 to 200 uCi/,ug.
Tissue preparation
Sheep brains were collected fresh from the abattoir and transported on ice before dissection (-30 min). The hypothalamus, midbrain and medulla oblongata were dissected free of surrounding tissue and either snap-frozen (for autoradiography) in isopentane at -40°C and stored at -70°C until use, or used to prepare membranes.
Membrane preparation
Dissected brainstem tissue was blended for 30 s in 4-5 vol. of lysis buffer [25 mM-Tris/HCl (pH 7.3)/1 mM-EDTA/1 mmphenylmethanesulphonyl fluoride (PMSF)] then homogenized in an Ultra-Turrax (13000 rev./min) for a further 2 min. The homogenate was centrifuged for 15 min at 1500 g and the supernatant was retained. The pellet was rehomogenized in an equal volume of lysis buffer and recentrifuged at 1500 g and the supernatant was again retained. The low-speed supernatants were then centrifuged for 20 min at 40000 g and the pellets were retained. The pellets were resuspended in lysis buffer with 3 strokes of a motorized glass-Teflon homogenizer then centrifuged again for 20 min at 40000 g. Pellets were resuspended in lysis buffer (2-3 mg/ml) and stored at -70°C until use. All procedures were carried out at 4 'C. Proteins were assayed by the Amido Black method (Schaffner & Weissman, 1973) .
Particulate membrane binding
Membranes were thawed and centrifuged at 48 000 g for 20 min at 4 'C and rehomogenized in 50 mM-Tris/HCI buffer, pH 7.3, containing 1 mM-PMSF, 1 mM-EDTA, I mg of bacitracin/ml and 0.2 % BSA (buffer A). Portions of membrane (-0.1 mg of protein/ml) were incubated as specified with 251I-sCT (0.1 nM) in the presence or absence of unlabelled sCT. Reactions were terminated by centrifugation in a Beckman Microfuge for 3 min at 4 'C. The pellets were overlaid with 1 ml of ice-cold phosphatebuffered saline (100 mM-phosphate) and Microfuged again for 90 s. The pellets were counted for radioactivity in a Packard y-radiation counter.
Autoradiography
Coronal sections (10-20 ,um) of hypothalamus were cut and processed for autoradiography as previously described . Sections were preincubated for 15 min in 50 mmTris/HCI buffer, pH 7.3, containing 100 mM-NaCl, 0.20% BSA and 0.4 mM-bacitracin at room temperature, and then incubated for 90 min in 5 ml of the same buffer containing pM) in the presence or absence of 0.1 /M unlabelled sCT.
The slide-mounted sections were then rapidly washed four times with 1 min transfers through 50 mM-Tris/HCI, pH 7.3, containing 100 mM-NaCl at 0 'C, and dried in a stream of cold air. The dried sections were exposed to Agfascopix CR3B (Agfa, Gevaert, Belgium) X-ray film for 7-21 days in X-ray cassettes.
Membrane solubilization
Membranes were thawed, centrifuged at 4°C for 20 min at 40000 g and resuspended with two strokes of a glass-Teflon homogenizer in an equivalent volume of solubilization buffer (50 mM-Tris/HCl, pH 7.3, containing 1 mM-EDTA, 1 mm-PMSF, 10mM-benzamidine, 10 jg of pepstatin/ml, 10ug of antipain/ml, 20 ,ig of leupeptin/ml and I mg of bacitracin/ml) and solubilized using 5 mM-CHAPS unless otherwise specified, for I h at 4 'C. After centrifugation at 100000 g for I h at 4 'C, supernatants were retained for use in binding characterization studies.
Binding of 125I-sCT to solubilized membranes (-0.03 mg of protein) was performed, and separation of bound and free CT was achieved by poly(ethylene glycol 6000) (PEG) precipitation as previously described . Briefly, 125I-sCT (0.1 nm unless otherwise specified) was incubated in solubilization buffer containing 0.2 % BSA. After incubation, bound and free tracer were separated by the addition of bovine y-globulin (I mg/ml) and PEG (10 %, w/v, final concentration) in 100 mMpotassium phosphate buffer, pH 7.3, followed by incubation on ice for either 10 min or 2 min (kinetic experiments) and centrifugation in a Beckman Microfuge for 5 min. No change in precipitated radioactivity was observed between the two incubation times. Pellets were counted for radioactivity in a Packard y-radiation counter with 70 % efficiency. Data are expressed as means of triplicate determinations. Binding data were analysed by the iterative curve-fitting program (LIGAND) of Munson & Rodbard (1980) . Values shown are means+S.E.M.;
S.E.M. values for binding studies are not shown but were less than 5 % of the means in all experiments.
Cross-linking studies Photoaffinity labelling was carried out on both particulate and CHAPS-solubilized membranes. All procedures before irradiation were implemented under safelight conditions. After centrifugation and rehomogenization in buffer A, sheep brain membranes (-2 mg of protein) were incubated for 18 h at 4 'C with 0.3 nM-1251I-[Arg""18,4-azidobenzoyl-Lys14]sCT in the presence or absence of unlabelled sCT. After incubation, the membranes were centrifuged in a Beckman Microfuge, washed and resuspended in 100 mM-phosphate buffer, pH 7.0, placed in a Petri dish on ice and irradiated for 15 min with a 100 W long-wave (peak emission 366 nm) u.v. lamp at a distance of 10 cm. They were then recentrifuged and the pellets were solubilized in 50 mMTris/HCl/l % (w/v) SDS/10% (v/v) glycerol/5% (v/v) /1-mercaptoethanol, pH 6.8 (sample buffer). Extracts were boiled for 3 min, centrifuged at 100000 g for 1 h and then analysed by SDS/PAGE by the method of Laemmli (1970) . Solubilized brain extracts were treated in a similar manner. After incubation and irradiation, 80 ,u1 portions (-250 ,ug of protein) were added to 80 ,u1 of 2 x concentrated sample buffer, boiled and analysed by SDS/PAGE. The resulting gels were subjected to autoradiography with Kodak X-AR 5 X-ray film in X-ray cassettes for -7 days.
ATP chromatography Solubilized brain extract (-40 mg total protein) was supplemented with 3 mM-MgCl2 and applied to a 1 ml ATP-agarose affinity column. Binding of 125I-sCT to solubilized material was assessed before chromatography and in column flow-through fractions. The column was then washed with 50 ml of buffer B
[50 mM-Tris/HCI, pH 7.4, 5 mM-CHAPS, 100% (v/v) for the particulate membranes were 0.98 + 0.24 nm and 0.9 + 0.2 pmol/mg of protein respectively. Binding was optimal in the pH range 6.5-7.5 (Fig. 4) Vol. 273 (Fig. 5) of human parathyroid hormone-(l-34) (1 4UM) to displace binding, whereas a-rat CGRP (1 4UM) induced only minor displacement of binding after 2 h at 4°C and had no effect at 22°C (results not shown).
Photoactive labelling Photoaffinity labelling of the receptor with the biologically active sCT analogue 125I-[Arg11 '8,4-azidobenzoyl-Lys'4]sCT, and analysis on SDS/PAGE and autoradiography, revealed a specific receptor band of Mr -72000 in both solubilized and particulate brain membranes (Fig. 6 ) These bands were not detected in the absence of photolysis or in the presence of excess unlabelled sCT (800 nM). A number of non-specific proteins of lower Mr were also observed.
ATP-agarose chromatography
Recently, Dana et al. (1990) indicated that members of the 70000-Mr family of heat-shock proteins can bind sCT with nanomolar affinity, and suggested that some binding sites studied in tissues such as placenta may be heat-shock proteins. These 1991 (b) in-, --U-, in-, U proteins, however, are unlikely to correspond to the binding site identified in the current study, as the 70000-M, heat-shock proteins avidly bind ATP and are retained on ATP-agarose (Welch & Feramisco, 1985; Dana et al., 1990) , whereas binding of 1251I-sCT to the solubilized sheep brain CT binding site was not altered by passage through ATP-agarose (results not shown).
DISCUSSION
Autoradiography of 125I-sCT binding in the sheep diencephalon illustrated high binding densities in parts of the hypothalamus, the amygdala and the hippocampus. Comparison of the patterns of binding across species demonstrates that highdensity binding to regions such as the hypothalamus, amygdala and caudoventral putamen is conserved in sheep, rat (Olgiati et al., 1983; Henke et al., 1983) , cat (Guidobono et al., 1987) and human (Sagar et al., 1984; P. M. Sexton, unpublished work) . However, the distribution of binding in cat and sheep is wider than that in rat and human, with binding present in the hippocampus and much of the thalamus, while the sheep appears to have an even broader distribution than does the cat, with binding also present in the cortex. Thus central CT receptors are likely to subserve a subset of similar functions in all species, but may also have additional actions in species such as sheep and cat.
Earlier attempts to solubilize CT receptors using the non-ionic detergents Lubrol PX (Queener et al., 1975) or /-octyl glucoside and Triton X-100 (J. M. Moseley, unpublished work) resulted in alterations in binding properties from those seen in either cells or membranes. Similarly, ,-octyl glucoside was ineffective in solubilizing CT binding sites in the current study. This may result from the inability of the long alkyl chains of ,J-octyl glucoside and the polyoxyethylene derivatives, which associate more readily with hydrophobic regions of the proteins, to disrupt the ionic interactions between the hydrophylic residues of the proteins (Helenius et al., 1979) . In this study, sheep brain CT binding sites were successfully solubilized with the zwitterionic and non-ionic steroid derivatives CHAPS and digitonin respectively. We have previously reported solubilization of functional CT receptors from human placental membranes using CHAPS . The differences in CHAPS concentration required for optimal solubilization of receptor in the brain (6-8 mM) and placenta (4-6 mM) probably reflect differences in the protein and lipid content of the two tissues. The success of both CHAPS and digitonin in solubilizing CT receptors may be related to the ability of these two steroid derivatives to substitute for cholesterol, a lipid which may stabilize the structures of certain membrane proteins (Rooney et al., 1984) .
Association of 1251I-sCT to both particulate and CHAPSsolubilized CT binding sites was time-and temperaturedependent, with optimal binding in the physiological ranges of pH and NaCl concentration. Furthermore, competition binding studies demonstrate that the relative binding potencies of various CTs in sheep brain is similar to that seen in other CT receptor systems (Findlay et al., 1980 (Findlay et al., , 1983 (Findlay et al., , 1985 Fischer et al., 1981a,b; Nicholson et al., 1986 Nicholson et al., , 1988 Sexton et al., 1987) . However, despite this similarity to other CT receptors, the sheep brain CT hormone-binding site complex was readily dissociable upon addition of excess unlabelled sCT. This is in contrast with CT receptors studied in osteoclasts (Nicholson et al., 1986 ) and in various CT-receptor-bearing cell lines (Findlay et al., 1980; Lamp et al., 1981) , where binding is virtually irreversible, or in kidney, where binding is slowly or incompletely reversible (Goltzman, 1980; Chao & Forte, 1983) . Furthermore, in rat (Fischer et al., 1981a ; P. M. Sexton, unpublished work) and human (Fischer et in sheep brain reflect a species variation in the behaviour of the receptor rather than tissue differences. High concentrations of CGRP induced a minor displacement of radiolabelled CT in solubilized membranes, consistent with the low cross-reactivity of CGRP with CT binding sites in rat brain (Goltzman & Mitchell, 1985; Henke et al., 1985) , whereas the unrelated parathyroid hormone had no effect, illustrating the specificity of the effect for CT. According to autoradiographic studies, both osteoclasts (D'Santos et al., 1988) and placenta contain two forms of the receptor of Mr -% 88000 and Mr -71000, whereas in the cell lines UMR 106-06 , BEN and T47D only the higher-Mr form has been resolved. In the current study, a single protein of Mr -72000 was identified, corresponding to the lower-Mr form of the receptor seen in osteoclasts and placenta. No evidence for a higher-Mr form of the protein was seen in sheep brain. Studies on the granulocyte/macrophage-colony-stimulating factor and interleukin 2 receptors .demonstrated two Mr forms of these receptors which correspond to high-and low-affinity binding states (Gearing et al., 1989; Hatakeyama et al., 1989) . These studies revealed that low-Mr/low-affinity forms require the association of another membrane protein(s) to acquire high affinity for the hormone. Indeed, only the high-affinity receptor is associated with ligand internalization and signal transduction. Evidence from renal cell binding studies, in which reversibility was observed at 4°C but not at 20°C, suggests that the occurrence of high-affinity binding may be an energy-dependent process (Chao & Forte, 1983) . Given the apparently lower affinity of the sheep brain binding site (as indicated by its more rapid dissociation), it is possible that low-affinity binding is a function of a lower-Mr form of the receptor, with high affinity conferred in the higher-Mr form of the receptor after coupling of a secondary protein, e.g. a guanine-nucleotide-binding protein.
The current results highlight the potential for heterogeneity in different CT receptor populations. Comparison of the biochemical characteristics and kinetics of CT binding sites in other sheep tissues (e.g. bone or kidney) and the brain of other species should help to elucidate the nature of the differences in CT binding observed between sheep brain and other systems.
